MTA3
MTA3 (Metastasis Associated 1 Family, Member 3) is a protein that in humans is encoded by the MTA3 gene. It is a part of the metastasis-associated protein (MTA) family, which plays a significant role in epigenetic regulation and gene expression. MTA3 has been implicated in various biological processes, including cell differentiation, development, and cancer progression. Its function is particularly notable in the context of epithelial-mesenchymal transition (EMT), a critical event in tumor metastasis and progression.
Function[edit | edit source]
MTA3 acts within the nucleosome remodeling and deacetylase (NuRD) complex, a multi-subunit complex that is involved in chromatin remodeling and histone deacetylation. This complex plays a crucial role in the regulation of gene expression by altering the chromatin structure, thereby affecting DNA accessibility to transcription factors. MTA3 specifically has been shown to regulate the expression of the Snail family of transcription factors, which are key regulators of EMT, suggesting a role in the suppression of tumor metastasis by inhibiting EMT.
Clinical Significance[edit | edit source]
The expression levels of MTA3 have been studied in various cancers, including breast cancer, colorectal cancer, and gastric cancer. In some studies, reduced expression of MTA3 has been associated with poor prognosis and increased metastatic potential. This is because the loss of MTA3 expression can lead to the activation of EMT, promoting cancer cell invasion and metastasis. Conversely, in certain contexts, MTA3 overexpression may contribute to the suppression of tumor progression, highlighting its potential as a biomarker for cancer prognosis and as a target for therapeutic intervention.
Research[edit | edit source]
Research on MTA3 continues to explore its precise molecular mechanisms and its potential role in other diseases beyond cancer. Understanding the regulation of MTA3 and its interaction with other components of the NuRD complex could provide insights into the development of novel therapeutic strategies targeting epigenetic regulators in cancer and other diseases.
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
